MARKET_TICKER: JNJ

JOHNSON & JOHNSONInsider Trading & SEC Form 4 Analysis

Institutional analysis of internal capital flows based on SEC Form 4 filings.

Executive Sentiment
BEARISH
SOURCE: EDGAR_SYSTEMSTATUS: VERIFIED
Net_Flow

-$60.8M

Buys minus sales
Last_Filing

2026.06.11

Latest Form 4
Active_Insiders

11

Reporting entities
Top_Buyer

No buyer detected

No open-market buys
Top_Seller

Wolk Joseph J

$8.1M

Automated_Intelligence_Report :: JNJ

Algorithmic analysis of recent insider trading activity for JNJ reveals a bearish posture among the C-suite and board members. Based on the latest SEC Form 4 filings, we have tracked capital events executed by 11 distinct corporate insiders. The aggregate nominal exposure during this reporting cycle reached $105.95M.

Market dynamics show a negative net capital flow of $60.76M when isolating open-market purchases versus open-market sales. The trading volume is heavily weighted towards open-market executions, providing a clearer signal of insider conviction regarding current valuation levels compared to option-based equity grants.

From a microstructural perspective, the most significant liquidity event was a divestment by Wolk Joseph J (Officer/Other), which accounts for a major share of the recent outflow. Continuous monitoring of these Tier-1 actors is essential, as their liquidity decisions often precede material corporate events or reflect an informed, asymmetric perspective on the future performance of JNJ.

Volume_30D

$105.95M

USD NOMINAL VALUE
Active_Insiders

11

UNIQUE C-SUITE ENTITIES
Last_Entry

2026.06.11

ISO_8601 FORMAT
Loading chart...
Entity / TimelineMethodologyPositionNet Value
Wengel Kathryn E2026.06.11
ACQUISITION10,000$1,156,700
Wengel Kathryn E2026.06.11
DISPOSAL10,000$2,411,500
REED JOHN C2026.05.01
ACQUISITION25,255$0
REED JOHN C2026.05.01
ACQUISITION11,002$2,528,809.7
Decker Robert J2026.02.27
ACQUISITION4,075$471,355.25
Decker Robert J2026.02.27
DISPOSAL4,075$1,010,070.25
Schmid Timothy2026.02.20
DISPOSAL1,322$324,762.52
Schmid Timothy2026.02.18
ACQUISITION13,625$1,576,003.75
Schmid Timothy2026.02.18
DISPOSAL13,625$3,327,225
Schmid Timothy2026.02.18
ACQUISITION8,998$1,165,330.98
Schmid Timothy2026.02.18
DISPOSAL8,998$2,200,280.94
Swanson James D.2026.02.17
ACQUISITION20,521$3,378,167.02
Swanson James D.2026.02.17
DISPOSAL20,521$4,980,446.7
Wolk Joseph J2026.02.17
ACQUISITION19,241$2,225,606.47
Wolk Joseph J2026.02.17
DISPOSAL19,241$4,675,370.59
Wolk Joseph J2026.02.17
ACQUISITION12,066$1,562,667.66
Wolk Joseph J2026.02.17
DISPOSAL12,066$2,930,469.42
Wolk Joseph J2026.02.17
ACQUISITION33,386$4,404,948.84
Wolk Joseph J2026.02.17
DISPOSAL33,386$8,104,451.5
Wolk Joseph J2026.02.17
DISPOSAL24,961$6,057,535.48
PAGE_ 1 _OF_ 5

Automated_Queries :: Frequently Asked Questions

>How many corporate insiders are active in JNJ?

Our dataset currently tracks 11 distinct insiders with reported transactions for JNJ in the active reporting window.

>Is insider buying outweighing selling at JNJ?

Open-market selling volume ($60.76M) currently exceeds buying volume ($0.00M), indicating net liquidation by insiders.

>Who is currently buying JNJ stock?

Our algorithmic tracking of SEC Form 4 filings indicates no significant open-market buying activity by major executives for JNJ in the recent reporting period.

Related_Analysis

SECTOR_PEERS :: Healthcare